LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr | ₹3,003 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹820 Cr |
Mar2023 | ₹992 Cr |
Mar2022 | ₹1,153 Cr |
Mar2021 | ₹1,136 Cr |
Mar2020 | ₹3,003 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹820 Cr | -17.38 | |
Mar2023 | ₹992 Cr | -13.96 | |
Mar2022 | ₹1,153 Cr | 1.50 | |
Mar2021 | ₹1,136 Cr | -62.17 | |
Mar2020 | ₹3,003 Cr | - |
Compare Total Non-Current Liabilities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹89,329.2 Cr | -5.4% | 3.4% | 26.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | -5.4% |
3.4% |
26.8% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses